With FilC at 5.1 ± 0.4-fold and the PD-1 inhibitor at 5.8 ± 0.5-fold, the H22 murine HCC cell line showed the highest expression levels, indicating effective transgenic expression in this highly proliferative malignant cell line. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.